Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |